Patents by Inventor Levi David Waldron

Levi David Waldron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LSC AND HSC SIGNATURES FOR PREDICTING SURVIVAL OF PATIENTS HAVING HEMATOLOGICAL CANCER
    Publication number: 20120237488
    Abstract: A method for determining prognosis in a subject having a hematological cancer comprising: a) determining an expression profile by measuring the gene expression levels of a set of genes selected from a leukemic stem cell (LSC) gene signature marker set or an hematopoietic stem cell (HSC) gene signature marker set, in a sample from a subject; and b) classifying the subject as having a good prognosis or a poor prognosis based on the expression profile; wherein a good prognosis predicts an increased likelihood of survival within a predetermined period after initial diagnosis and poor prognosis predicts a decreased likelihood of survival within the predetermined period after initial diagnosis.
    Type: Application
    Filed: December 3, 2010
    Publication date: September 20, 2012
    Applicants: UNIVERSITY HEALTH NETWORK, THE BRIGHAM AND WOMEN'S HOSPITAL, INC., THE HOSPITAL FOR SICK CHILDREN
    Inventors: John Dick, Kolja Eppert, Igor Jurisica, Levi David Waldron, Mark Minden, Eric Lechman, Bjorn Nilsson, Benjamin Levine Ebert, Katsuto Takenaka, Jayne S. Danska